Stay informed with the latest updates for the inheritable blood disorders community. IndustryJanssen's HCV Therapy Receives FDA Priority ReviewJun 1, 2013 IndustryBayer Discontinues rFVIIa Therapy TrialJun 1, 2013 IndustryAntiviral Oral Combination Treats Certain HCV PatientsMay 1, 2013 IndustryAchillion Drug Begins Phase 2 Trial in HCV PatientsMay 1, 2013 IndustryGilead Announces HCV Drug Sofosbuvir Clinical Trial ResultsMay 1, 2013 IndustryCSL Donates to WFH GAP ProgramMay 1, 2013 IndustryBaxter Submits FDA Application for Prophylactic FEIBA for Inhibitor…Apr 1, 2013 IndustryPfizer Halts Development of HCV DrugApr 1, 2013 IndustryFDA Accepts Biogen's Application for Longer-Lasting FVIII ProductApr 1, 2013 IndustryCSL's FXIII Product Approved for Expanded UseApr 1, 2013 IndustryBiogen Reports A-LONG and B-LONG Studies ProgressMar 1, 2013 IndustryGilead's HCV Therapy Trials On TrackMar 1, 2013 IndustryIdenix Ceases Development of Two HCV DrugsMar 1, 2013 IndustryCangene to Acquire IB1001 from InspirationMar 1, 2013 IndustryCSL Behring Enrolls Pediatric Patient in Hemophilia B StudyFeb 1, 2013 Pagination First page Previous page … Page 14 Page 15 Page 16 Page 17 Current page 18 Page 19 Page 20 Page 21 Page 22 … Next page Last page
